Tenet Healthcare (THC) Tops Q3 EPS by 24c, Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $1.44, $0.24 better than the analyst estimate of $1.20. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $5.02 billion.

GUIDANCE:

Tenet Healthcare sees Q4 2023 EPS of $1.12-$1.74, versus the consensus of $1.75. Tenet Healthcare sees Q4 2023 revenue of $5.131-5.331 billion, versus the consensus of $5.25 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance